Related Experiment Video
Updated: Jun 18, 2026

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
Laparoendoscopic single-site and conventional laparoscopic adrenalectomy: a matched case-control study
Byong Chang Jeong1, Yong Hyun Park, Deok Hyun Han
1Department of Urology, Sungkyunkwan University College of Medicine, Seoul, Korea.
Journal of Endourology
|November 14, 2009
Summary
Laparoendoscopic single-site surgery (LESS) for benign adrenal adenoma is comparable to conventional laparoscopy. LESS demonstrated reduced postoperative pain and comparable outcomes, offering a feasible alternative with better cosmetic results.
Area of Science:
- Minimally Invasive Surgery
- Surgical Oncology
- Urology
Background:
- Benign adrenal adenomas are common endocrine tumors.
- Conventional laparoscopic adrenalectomy is a standard treatment.
- Advancements in surgical techniques aim to improve patient outcomes and cosmesis.
Purpose of the Study:
- To evaluate the initial clinical experience with laparoendoscopic single-site surgery (LESS) for benign adrenal adenoma.
- To assess the feasibility and safety of LESS adrenalectomy.
- To compare LESS with conventional laparoscopic adrenalectomy.
Main Methods:
- A retrospective comparison of 9 patients undergoing LESS adrenalectomy with 17 patients undergoing conventional laparoscopic adrenalectomy.
- Patients were matched for age, sex, indications, and tumor size.
- Outcomes analyzed included operative time, blood loss, postoperative hospital stay, pain, and complications.
Main Results:
- No significant differences were found in operative time, blood loss, or hospital stay between LESS and conventional laparoscopy.
- Postoperative pain, measured by IV patient-controlled anesthesia use, was significantly lower in the LESS group (0.9 vs. 1.9 days, p = 0.047).
- Perioperative complication rates were similar between the two groups.
Conclusions:
- LESS adrenalectomy is a feasible and comparable alternative to conventional laparoscopy for benign adrenal adenoma.
- LESS offers potential benefits in terms of reduced postoperative pain and improved cosmetic outcomes.
- Further research may explore wider adoption of LESS for adrenal pathologies.
